SRF slips 4% as UBS downgrades to 'Sell' from 'Buy'; sees downside of 22%
The market's expectation of a demand recovery for SRF's chemical segment will be met with disappointment, UBS said
)
Explore Business Standard
Associate Sponsors
The market's expectation of a demand recovery for SRF's chemical segment will be met with disappointment, UBS said
)
First Published: Oct 17 2024 | 9:37 AM IST